Stay updated on Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial page.

Latest updates to the Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial page
- Check3 days agoChange DetectedA new version of the clinical trial record was submitted on November 10, 2026, updating key study information and contacts/locations. The record history also reflects a change to a previously listed submission date.SummaryDifference0.5%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe site footer now identifies the website release as v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check24 days agoChange DetectedA site-wide NIH notice says federal agencies are transitioning to the term “Super Intelligence” in place of “Artificial Intelligence” and directs visitors to transition updates and FAQs.SummaryDifference0.4%

- Check31 days agoChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.7.1 to v3.7.2. The study record history remains unchanged.SummaryDifference0.1%

- Check38 days agoChange DetectedThe site revision was updated from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check59 days agoChange DetectedThe Find Contact Information label was updated to Find contact information and the revision badge changed from v3.6.6 to v3.7.0, reflecting a minor UI/version update.SummaryDifference0.1%

Stay in the know with updates to Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial page.